Quantcast

Latest Brain tumor Stories

2014-05-22 23:07:52

American Brain Tumor Association Conference to Be Held July 25 - 26 Chicago, IL (PRWEB) May 22, 2014 The American Brain Tumor Association will host its annual patient and family conference, the largest research, education and networking event solely dedicated to advancing the understanding of the latest brain tumor research, treatment and caregiving strategies, on July 25 & 26, at the Renaissance Chicago O’Hare Suites, in Chicago. Brain tumor experts from across the country are...

2014-05-22 23:07:02

Over 400 medical professionals from around the world attended the conference which featured over 100 presentations discussing the growing applications of SRS/SBRT in the treatment of tumors of the brain, spine, lung, breast, prostate, liver, pancreas and head and neck. Campbell, California (PRWEB) May 22, 2014 The Radiosurgery Society® (RSS), a non-profit organization of medical professionals dedicated to advancing the science and clinical practice of stereotactic radiosurgery (SRS)...

2014-05-22 08:29:48

In Addition, Toca 511 Clinical Data to be Presented at American Society of Clinical Oncology Annual Meeting SAN DIEGO, May 22, 2014 /PRNewswire/ -- Tocagen Inc. today announced multiple scientific contributions at the American Society of Gene and Cell Therapy (ASGCT) 17(th) Annual Meeting, held May 21 to 24, 2014 at the Marriott Wardman Park in Washington, DC. At the ASGCT Annual Meeting, data from clinical and preclinical studies of Toca 511 will be presented in two podium presentations:...

2014-05-21 13:51:36

University of California - San Diego Tumor modeling predicts most effective drugs targeting brain cancer Researchers at University of California, San Diego School of Medicine and Moores Cancer Center have used computer simulations of cancer cells – cancer avatars – to identify drugs most likely to kill cancer cells isolated from patients' brain tumors. The findings, published in May 21 online issue of the Journal of Translational Medicine, may help researchers stratify cancer...

2014-05-21 08:29:53

Multi-institutional radiotherapy planning study compared Leksell Gamma Knife Perfexion with three advanced linear-accelerator based stereotactic radiosurgery systems NEW YORK, May 21, 2014 /PRNewswire/ -- Persons who need radiotherapy for treatment of multiple brain metastases stand to receive as much as a 74 percent lower radiation dose to normal brain tissue if the lesions are treated with Elekta's Leksell Gamma Knife® Perfexion(TM) radiosurgery system versus contemporary...

2014-05-20 23:08:25

Barnes-Jewish Hospital was one of the first hospitals in the country to offer patients the opportunity to have brain surgery using technology that reduced the need for follow-up surgery. Now, its neurosurgery team has reached a milestone by performing more than 1,000 cases using its moveable intraoperative MRI system – more than any other center in the United States. St. Louis (PRWEB) May 20, 2014 Barnes-Jewish Hospital was one of the first hospitals in the country to offer patients the...

2014-05-20 20:22:05

VANCOUVER, British Columbia and MENLO PARK, Calif., May 20, 2014 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar" and "DelMar Pharma") provided a quarterly update and a summary of progress toward the Company's goals for the year. DelMar also announced an investor conference call to take place on Thursday June 5, 2014 at 11:30 am EDT. Details and log-in information will be posted on the website at www.delmarpharma.com in advance of the call. Highlights from the...

2014-05-20 08:31:42

CALGARY, May 20, 2014 /PRNewswire/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC) (NASDAQ:ONCY) today announced that an abstract detailing early results from translational study looking at the intravenous administration of REOLYSIN(®) to patients with primary or metastatic brain tumors is now available on the ASCO Annual Meeting abstract website at http://abstracts.asco.org. The conference is being held from May 30(th) to June 3(rd), 2014 in Chicago, Illinois. "Treatment...

2014-05-19 08:28:02

A registry of 457 recurrent glioblastoma patients shows that patients treated commercially with NovoTTF Therapy in 2012 and 2013 achieved the longest median overall survival yet shown in non-experimental use for patients with recurrent glioblastoma NEW YORK, May 19, 2014 /PRNewswire/ -- Novocure, a commercial stage oncology company, announced today that an analysis of the efficacy and safety data from its U.S. patient registry will be published as part of the 50(th) meeting of the...

herpes virus attack a brain tumor cell
2014-05-18 03:00:47

Harvard Stem Cell Institute (HSCI) Harvard Stem Cell Institute (HSCI) scientists at Massachusetts General Hospital have a potential solution for how to more effectively kill tumor cells using cancer-killing viruses. The investigators report that trapping virus-loaded stem cells in a gel and applying them to tumors significantly improved survival in mice with glioblastoma multiforme, the most common brain tumor in human adults and also the most difficult to treat. The work, led by Khalid...


Word of the Day
malpais
  • The ragged surface of a lava-flow.
'Malpais' translates from Spanish as 'bad land.'